{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T16:48:37Z","timestamp":1774370917883,"version":"3.50.1"},"reference-count":33,"publisher":"American Veterinary Medical Association (AVMA)","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["javma"],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n<jats:sec>\n<jats:title>Objective<\/jats:title>\n<jats:p>To characterize the effects of inhaled albuterol on blood potassium and glucose concentrations, heart rate (HR), and plasma insulin levels in normokalemic cats.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>In a prospective, randomized study between June 2023 and January 2024, 20 client-owned cats received albuterol sulfate at a low dose (90 \u00b5g) or high dose (360 \u00b5g). Blood samples and HR were obtained at baseline and 10 time points after albuterol delivery. Blood potassium and glucose concentrations were measured via blood gas analyzer and plasma insulin levels by radioimmunoassay.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Blood potassium concentrations decreased rapidly after albuterol delivery compared to baseline for the low dose and high dose within 3 minutes and remained significantly decreased until 180 minutes. The maximal decrease in potassium concentration for albuterol at the low dose was \u20130.52 mmol\/L (95% CI, \u20130.66 to \u20130.37) and high dose was \u20130.38 mmol\/L (95% CI, \u20130.52 to \u20130.23) and occurred at 30 minutes for both doses. Plasma insulin levels rapidly increased, with peak effect at 30 minutes for both the low dose (5.10 \u00b5IU\/mL; 95% CI, 2.79 to 7.40) and high dose (3.86 \u00b5IU\/mL; 95% CI, 1.49 to 6.22). There was no correlation between nadir potassium concentration and albuterol dose (<jats:italic>r<\/jats:italic> = 0.12).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Albuterol rapidly decreases blood potassium concentrations in part by stimulating endogenous insulin secretion in cats without dose-dependent effects or clinically meaningful changes in HR or glucose concentrations.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Clinical Relevance<\/jats:title>\n<jats:p>Inhaled albuterol may be useful to decrease blood potassium concentrations in hyperkalemic cats.<\/jats:p>\n<\/jats:sec>","DOI":"10.2460\/javma.25.01.0054","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T13:42:02Z","timestamp":1742996522000},"page":"971-978","source":"Crossref","is-referenced-by-count":3,"title":["Inhaled albuterol rapidly decreases whole blood potassium and increases plasma insulin concentrations, with peak effects 30 minutes after administration in cats"],"prefix":"10.2460","volume":"263","author":[{"given":"Jared A.","family":"Jaffey","sequence":"first","affiliation":[{"name":"Department of Specialty Medicine, College of Veterinary Medicine, Midwestern University, Glendale, AZ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anderson da","family":"Cunha","sequence":"additional","affiliation":[{"name":"Department of Specialty Medicine, College of Veterinary Medicine, Midwestern University, Glendale, AZ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tokiko","family":"Kushiro-Banker","sequence":"additional","affiliation":[{"name":"Department of Specialty Medicine, College of Veterinary Medicine, Midwestern University, Glendale, AZ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata S.","family":"Costa","sequence":"additional","affiliation":[{"name":"Department of Specialty Medicine, College of Veterinary Medicine, Midwestern University, Glendale, AZ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Acierno","sequence":"additional","affiliation":[{"name":"Department of Specialty Medicine, College of Veterinary Medicine, Midwestern University, Glendale, AZ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chase","family":"Irwin","sequence":"additional","affiliation":[{"name":"Office of Research and Sponsored Programs, Midwestern University, Glendale, AZ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Chittick","sequence":"additional","affiliation":[{"name":"Department of Specialty Medicine, College of Veterinary Medicine, Midwestern University, Glendale, AZ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natacha","family":"Montalvo","sequence":"additional","affiliation":[{"name":"Office of Clinical Research Services, College of Veterinary Medicine, Midwestern University, Glendale, AZ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mia","family":"Felix","sequence":"additional","affiliation":[{"name":"Department of Specialty Medicine, College of Veterinary Medicine, Midwestern University, Glendale, AZ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Valentine","sequence":"additional","affiliation":[{"name":"Department of Specialty Medicine, College of Veterinary Medicine, Midwestern University, Glendale, AZ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gurpinder","family":"Dhaliwal","sequence":"additional","affiliation":[{"name":"Department of Specialty Medicine, College of Veterinary Medicine, Midwestern University, Glendale, AZ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean M.","family":"Brudvig","sequence":"additional","affiliation":[{"name":"Veterinary Diagnostic Laboratory, College of Veterinary Medicine, Michigan State University, Lansing, MI"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1272","reference":[{"key":"ref1","series-title":"Fluid, Electrolyte, and Acid-Base Disorders in Small Animal Practice","first-page":"92","article-title":"Disorders of potassium: hypokalemia and hyperkalemia","author":"DiBartola SP","year":"2012","unstructured":"DiBartola SP, De Morais HA. Disorders of potassium: hypokalemia and hyperkalemia. In: DiBartola SP, ed. Fluid, Electrolyte, and Acid-Base Disorders in Small Animal Practice. 4th ed. Elsevier\/Saunders; 2012:92-119."},{"issue":"6","key":"ref2","series-title":"J Vet Emerg Crit Care (San Antonio)","first-page":"653","article-title":"Retrospective evaluation of the severity of and prognosis associated with potassium abnormalities in dogs and cats presenting to an emergency room (January 2014-August 2015): 2441 cases","volume":"29","author":"Hoehne SN","year":"2019","unstructured":"Hoehne SN, Hopper K, Epstein SE. Retrospective evaluation of the severity of and prognosis associated with potassium abnormalities in dogs and cats presenting to an emergency room (January 2014-August 2015): 2441 cases. J Vet Emerg Crit Care (San Antonio). 2019;29(6):653-661. doi:10.1111\/vec.12889"},{"key":"ref3","series-title":"Small Animal Critical Care Medicine","first-page":"326","article-title":"Potassium disorders","author":"Wigglesworth SSM","year":"2023","unstructured":"Wigglesworth SSM. Potassium disorders. In: Silverstein DC, Hopper K, eds. Small Animal Critical Care Medicine. 3rd ed. Saunders; 2023:326-332. doi:10.1016\/B978-0-323-76469-8.00065-4"},{"issue":"3","key":"ref4","series-title":"Curr Heart Fail Rep","first-page":"67","article-title":"Acute management of hyperkalemia","volume":"16","author":"Liu M","year":"2019","unstructured":"Liu M, Rafique Z. Acute management of hyperkalemia. Curr Heart Fail Rep. 2019;16(3):67-74. doi:10.1007\/s11897-019-00425-2"},{"issue":"5","key":"ref5","series-title":"Anesth Analg","first-page":"1518","article-title":"A randomized, double-blind comparison of lactated Ringer\u2019s solution and 0.9% NaCl during renal transplantation","volume":"100","author":"O\u2019Malley CMN","year":"2005","unstructured":"O\u2019Malley CMN, Frumento RJ, Hardy MA,  A randomized, double-blind comparison of lactated Ringer\u2019s solution and 0.9% NaCl during renal transplantation. Anesth Analg. 2005;100(5):1518-1524. doi:10.1213\/01.ANE.0000150939.28904.81"},{"issue":"4","key":"ref6","series-title":"Kidney Int","first-page":"422","article-title":"Program to Improve Care in Acute Renal Disease (PICARD) Study Group. Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury","volume":"76","author":"Bouchard J","year":"2009","unstructured":"Bouchard J, Soroko SB, Chertow GM, ; Program to Improve Care in Acute Renal Disease (PICARD) Study Group. Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int. 2009;76(4):422-427. doi:10.1038\/ki.2009.159"},{"issue":"2","key":"ref7","series-title":"Vet Clin North Am Small Anim Pract","first-page":"255","article-title":"Pathophysiology of urethral obstruction","volume":"26","author":"Bartges JW","year":"1996","unstructured":"Bartges JW, Finco DR, Polzin DJ, Osborne CA, Barsanti JA, Brown SA. Pathophysiology of urethral obstruction. Vet Clin North Am Small Anim Pract. 1996;26(2):255-264. doi:10.1016\/S0195-5616(96)50206-8"},{"issue":"4","key":"ref8","series-title":"Vet Clin North Am Small Anim Pract","first-page":"843","article-title":"Management of urinary tract emergencies in small animals","volume":"43","author":"Balakrishnan A","year":"2013","unstructured":"Balakrishnan A, Drobatz KJ. Management of urinary tract emergencies in small animals. Vet Clin North Am Small Anim Pract. 2013;43(4):843-867. doi:10.1016\/j.cvsm.2013.03.013"},{"issue":"10","key":"ref9","series-title":"Cochrane Database Syst Rev","first-page":"CD010344","article-title":"Pharmacological interventions for the acute management of hyperkalaemia in adults","volume":"10","author":"Batterink J","year":"2015","unstructured":"Batterink J, Cessford TA, Taylor RA. Pharmacological interventions for the acute management of hyperkalaemia in adults. Cochrane Database Syst Rev. 2015;10(10):CD010344. doi:10.1002\/14651858.CD010344.pub2"},{"issue":"3","key":"ref10","series-title":"Chest","first-page":"617","article-title":"Salbutamol metered-dose inhaler with spacer for hyperkalemia: how fast? How safe?","volume":"115","author":"Mandelberg A","year":"1999","unstructured":"Mandelberg A, Krupnik Z, Houri S,  Salbutamol metered-dose inhaler with spacer for hyperkalemia: how fast? How safe? Chest. 1999;115(3):617-622. doi:10.1378\/chest.115.3.617"},{"issue":"3","key":"ref11","series-title":"Cell Biochem Biophys","first-page":"303","article-title":"The Na,K-ATPase receptor complex: its organization and membership","volume":"46","author":"Pierre SV","year":"2006","unstructured":"Pierre SV, Xie Z. The Na,K-ATPase receptor complex: its organization and membership. Cell Biochem Biophys. 2006;46(3):303-316. doi:10.1385\/CBB:46:3:303"},{"issue":"5","key":"ref12","series-title":"Kidney Int","first-page":"869","article-title":"Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients","volume":"38","author":"Allon M","year":"1990","unstructured":"Allon M, Copkney C. Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients. Kidney Int. 1990;38(5):869-872. doi:10.1038\/ki.1990.284"},{"issue":"6","key":"ref13","series-title":"Ann Intern Med","first-page":"426","article-title":"Nebulized albuterol for acute hyperkalemia in patients on hemodialysis","volume":"110","author":"Allon M","year":"1989","unstructured":"Allon M, Dunlay R, Copkney C. Nebulized albuterol for acute hyperkalemia in patients on hemodialysis. Ann Intern Med. 1989;110(6):426-429. doi:10.7326\/0003-4819-110-6-426"},{"issue":"4","key":"ref14","series-title":"Am J Kidney Dis","first-page":"607","article-title":"Effect of albuterol treatment on subsequent dialytic potassium removal","volume":"26","author":"Allon M","year":"1995","unstructured":"Allon M, Shanklin N. Effect of albuterol treatment on subsequent dialytic potassium removal. Am J Kidney Dis. 1995;26(4):607-613. doi:10.1016\/0272-6386(95)90597-9"},{"issue":"1","key":"ref15","series-title":"Ann Pharmacother","first-page":"103","article-title":"Albuterol for the treatment of hyperkalemia","volume":"33","author":"Wong SL","year":"1999","unstructured":"Wong SL, Maltz HC. Albuterol for the treatment of hyperkalemia. Ann Pharmacother. 1999;33(1):103-106. doi:10.1345\/aph.18070"},{"issue":"1","key":"ref16","series-title":"J Pediatr","first-page":"16","article-title":"Efficacy of albuterol inhalation in treatment of hyperkalemia in premature neonates","volume":"141","author":"Singh BS","year":"2002","unstructured":"Singh BS, Sadiq HF, Noguchi A, Keenan WJ. Efficacy of albuterol inhalation in treatment of hyperkalemia in premature neonates. J Pediatr. 2002;141(1):16-20. doi:10.1067\/mpd.2002.125229"},{"issue":"6","key":"ref17","series-title":"J Vet Intern Med","first-page":"2002","article-title":"Effect of inhaled albuterol on whole blood potassium concentrations in dogs","volume":"36","author":"Ogrodny A","year":"2022","unstructured":"Ogrodny A, Jaffey JA, Kreisler R,  Effect of inhaled albuterol on whole blood potassium concentrations in dogs. J Vet Intern Med. 2022;36(6):2002-2008. doi:10.1111\/jvim.16552"},{"issue":"4","key":"ref18","series-title":"J Pharmacol Pharmacother","first-page":"266","article-title":"Effect of heparin and low-molecular weight heparin on serum potassium and sodium levels","volume":"2","author":"Bengalorkar GM","year":"2011","unstructured":"Bengalorkar GM, Sarala N, Venkatrathnamma PN, Kumar TN. Effect of heparin and low-molecular weight heparin on serum potassium and sodium levels. J Pharmacol Pharmacother. 2011;2(4):266-269. doi:10.4103\/0976-500X.85956"},{"issue":"6","key":"ref19","series-title":"Am J Med","first-page":"575","article-title":"Heparin-induced aldosterone suppression and hyperkalemia","volume":"98","author":"Oster JR","year":"1995","unstructured":"Oster JR, Singer I, Fishman LM. Heparin-induced aldosterone suppression and hyperkalemia. Am J Med. 1995;98(6):575-586. doi:10.1016\/S0002-9343(99)80017-5"},{"key":"ref20","series-title":"Small Animal Critical Care Medicine","first-page":"6","article-title":"Physical examination and daily assessment of the critically ill patient","author":"Hackett TB","year":"2015","unstructured":"Hackett TB. Physical examination and daily assessment of the critically ill patient. In: Silverstein DC, Hopper K, eds. Small Animal Critical Care Medicine. Elsevier; 2015:6-10. doi:10.1016\/B978-1-4557-0306-7.00002-7"},{"issue":"4","key":"ref21","series-title":"J Vet Intern Med","first-page":"1703","article-title":"Validation of a flash glucose monitoring system in outpatient diabetic cats","volume":"35","author":"Shea EK","year":"2021","unstructured":"Shea EK, Hess RS. Validation of a flash glucose monitoring system in outpatient diabetic cats. J Vet Intern Med. 2021;35(4):1703-1712. doi:10.1111\/jvim.16216"},{"key":"ref22","series-title":"Foundations of Clinical Research: Applications to Practice","author":"Portney LG","year":"2009","unstructured":"Portney LG, Watkins MP. Foundations of Clinical Research: Applications to Practice. Pearson\/Prentice Hall; 2009."},{"issue":"1","key":"ref23","series-title":"J Intern Med","first-page":"35","article-title":"Treatment of hyperkalaemia in renal failure with salbutamol inhalation","volume":"228","author":"Montoliu J","year":"1990","unstructured":"Montoliu J, Almirall J, Ponz E, Campistol JM, Revert L. Treatment of hyperkalaemia in renal failure with salbutamol inhalation. J Intern Med. 1990;228(1):35-37. doi:10.1111\/j.1365-2796.1990.tb00189.x"},{"issue":"2","key":"ref24","series-title":"Arch Dis Child","first-page":"126","article-title":"Treatment of hyperkalaemia using intravenous and nebulised salbutamol","volume":"70","author":"McClure RJ","year":"1994","unstructured":"McClure RJ, Prasad VK, Brocklebank JT. Treatment of hyperkalaemia using intravenous and nebulised salbutamol. Arch Dis Child. 1994;70(2):126-128. doi:10.1136\/adc.70.2.126"},{"issue":"1","key":"ref25","series-title":"J Emerg Med","first-page":"13","article-title":"Levalbuterol is as effective as racemic albuterol in lowering serum potassium","volume":"25","author":"Pancu D","year":"2003","unstructured":"Pancu D, LaFlamme M, Evans E, Reed J. Levalbuterol is as effective as racemic albuterol in lowering serum potassium. J Emerg Med. 2003;25(1):13-16. doi:10.1016\/S0736-4679(03)00133-1"},{"issue":"6","key":"ref26","series-title":"Acad Emerg Med","first-page":"718","article-title":"Effect of nebulized albuterol on serum lactate and potassium in healthy subjects","volume":"23","author":"Zitek T","year":"2016","unstructured":"Zitek T, Cleveland N, Rahbar A,  Effect of nebulized albuterol on serum lactate and potassium in healthy subjects. Acad Emerg Med. 2016;23(6):718-721. doi:10.1111\/acem.12937"},{"issue":"2","key":"ref27","series-title":"Am J Kidney Dis","first-page":"266","article-title":"Hypokalemic effects of intravenous infusion or nebulization of salbutamol in patients with chronic renal failure: comparative study","volume":"23","author":"Liou HH","year":"1994","unstructured":"Liou HH, Chiang SS, Wu SC,  Hypokalemic effects of intravenous infusion or nebulization of salbutamol in patients with chronic renal failure: comparative study. Am J Kidney Dis. 1994;23(2):266-271. doi:10.1016\/S0272-6386(12)80983-8"},{"issue":"1","key":"ref28","series-title":"J Chin Med Assoc","first-page":"55","article-title":"Nebulized salbutamol diminish the blood glucose fluctuation in the treatment of non-oliguric hyperkalemia of premature infants","volume":"82","author":"Saw HP","year":"2019","unstructured":"Saw HP, Chiu CD, Chiu YP, Ji HR, Chen JY. Nebulized salbutamol diminish the blood glucose fluctuation in the treatment of non-oliguric hyperkalemia of premature infants. J Chin Med Assoc. 2019;82(1):55-59. doi:10.1016\/j.jcma.2018.04.002"},{"issue":"4","key":"ref29","series-title":"Adv Physiol Educ","first-page":"480","article-title":"Physiology and pathophysiology of potassium homeostasis","volume":"40","author":"Palmer BF","year":"2016","unstructured":"Palmer BF, Clegg DJ. Physiology and pathophysiology of potassium homeostasis. Adv Physiol Educ. 2016;40(4):480-490. doi:10.1152\/advan.00121.2016"},{"issue":"6058","key":"ref30","series-title":"BMJ","first-page":"413","article-title":"Metabolic effects of salbutamol: comparison of aerosol and intravenous administration","volume":"1","author":"Neville A","year":"1977","unstructured":"Neville A, Palmer JB, Gaddie J, May CS, Palmer KN, Murchison LE. Metabolic effects of salbutamol: comparison of aerosol and intravenous administration. BMJ. 1977;1(6058):413-414. doi:10.1136\/bmj.1.6058.413"},{"issue":"3","key":"ref31","series-title":"J Clin Invest","first-page":"682","article-title":"Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man","volume":"65","author":"Rizza RA","year":"1980","unstructured":"Rizza RA, Cryer PE, Haymond MW, Gerich JE. Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man. J Clin Invest. 1980;65(3):682-689. doi:10.1172\/JCI109714"},{"issue":"12","key":"ref32","series-title":"J Feline Med Surg","first-page":"e580","article-title":"Treatment strategies for hyperkalemia secondary to urethral obstruction in 50 male cats: 2002-2017","volume":"24","author":"Jones JM","year":"2022","unstructured":"Jones JM, Burkitt-Creedon JM, Epstein SE. Treatment strategies for hyperkalemia secondary to urethral obstruction in 50 male cats: 2002-2017. J Feline Med Surg. 2022;24(12):e580-e587. doi:10.1177\/1098612X221127234"},{"issue":"8","key":"ref33","series-title":"East Afr Med J","first-page":"503","article-title":"Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches","volume":"74","author":"Ngugi NN","year":"1997","unstructured":"Ngugi NN, McLigeyo SO, Kayima JK. Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches. East Afr Med J. 1997;74(8):503-509."}],"container-title":["Journal of the American Veterinary Medical Association"],"original-title":[],"link":[{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/javma\/263\/8\/javma.25.01.0054.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/javma\/263\/8\/javma.25.01.0054.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/javma\/263\/8\/javma.25.01.0054.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T04:23:10Z","timestamp":1754972590000},"score":1,"resource":{"primary":{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/javma\/263\/8\/javma.25.01.0054.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":33,"journal-issue":{"issue":"8"},"URL":"https:\/\/doi.org\/10.2460\/javma.25.01.0054","relation":{},"ISSN":["0003-1488"],"issn-type":[{"value":"0003-1488","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,1]]}}}